Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500105583Phase 4Not yet recruiting
Phase 4, randomised trial of Sulfadiazine in burn injury (2 arms), sponsored by Chengdu Second People's Hospital. Primary endpoint: Wound healing time. Planned start Jul 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500105583.